EN
HI
Divi's Laboratories Chart
Divi's Laboratories Share Key Metrics
Volume
1.63 L
Market Cap
176218.04 CR
LTQ@LTP
1@6638.00
ATP
6655.1
Var Margin
13.01 %
Circuit Range
5990-7321
Delivery %
46.09 %
Value
108.35 CR
ASM/GSM
No
Market Lot
1
Summary
Divi's Laboratories share price is ₹6638 as of 14 Jun, 2026. The stock Divi's Laboratories intraday movement has stayed between ₹6622.00 and ₹6738.50, while on a 52-week basis,Divi's Laboratories price 52 week high is ₹7071.50 & its 52 week low is ₹5636.50.
In terms of trading activity, Divi's Laboratories has recorded a volume of 162810 shares, The Divi's Laboratories has a market cap of ₹265468580 CR. The stock’s Average Traded Price (ATP) stands at ₹6655.10, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹6638.00.
Divi's Laboratories operates within a circuit range of ₹5990.00 – ₹7321.00, with a Value of ₹108.35 CR. The Delivery Percentage for the day is 46.09%. Additionally, Divi's Laboratories currently falls under the No framework, and trades with a market lot size of 1.
Divi's Laboratories Fundamentals
P/E Ratio
68.76
P/B Ratio
10.53
Div. Yield
0.45
Sector P/E
69.77
Sector P/B
2.99
Sec. Div. Yield
0.54
Divi's Laboratories Resistance and Support
Pivot 6666.83
Resistance
First Resistance
6708.66
Second Resistance
6761.83
Third Resistance
6803.66
Support
First Support
6613.66
Second Support
6571.83
Third Support
6518.66
Divi's Laboratories Futures & Options
Divi's Laboratories Option Chain
View Price, OI, Greeks & More...
30JUN26
6679.00
-4.50 (0.07%)
28JUL26
6675.00
-11.50 (0.17%)
25AUG26
6721.00
-9.00 (0.13%)
DIVISLAB|30JUN26 CE 6600.00
150.00
-13.35 (-8.17%)
DIVISLAB|30JUN26 PE 6650.00
96.75
-3.85 (-3.83%)
Divi's Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-23 | Audited Results & Dividend |
| 2026-02-11 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-08-06 | Quarterly Results |
| 2025-05-17 | Audited Results & Dividend |
| 2025-02-03 | Quarterly Results |
Divi's Laboratories News
Divis Laboratories Ltd - 532488 - Information Regarding Deduction Of Income Tax At Source From Payment Of Dividend For The Financial Year 2025-26
Divis Laboratories announced comprehensive information regarding the tax deduction at source (TDS) for its Rs.30 per share dividend for FY26. The record date for this dividend has been fixed as July 24, 2026, with guidelines for shareholders to claim exemptions provided.
Jun 11 2026 09:08:27
Divis Laboratories Ltd - 532488 - Outcome Of Board Meeting - Dividend Recommended
Divi's Laboratories fixed July 24, 2026, as record date for a final dividend of ₹30 per equity share for FY2025-26. This dividend, representing 1500% on face value, awaits shareholder approval at the upcoming 36th AGM.
May 23 2026 12:20:31
Divi's Laboratories Management
| Name | Position |
|---|---|
| M Satish Choudhury | Company Secretary & Compliance Officer |
| Murali K Divi | Managing Director |
Divi's Laboratories Similar Stocks
Sun Pharmaceutical Industries Ltd.
1807.70
13.50 (0.75%)
Torrent Pharmaceuticals Ltd.
4571.20
-1.00 (0.02%)
Apollo Hospitals Enterprise Ltd.
8498.00
5.00 (0.06%)
Cipla Ltd.
1389.40
6.10 (0.44%)
Zydus Lifesciences Ltd.
1104.70
-1.20 (0.11%)
Dr. Reddy's Laboratories Ltd.
1275.40
-0.60 (0.05%)
Lupin Ltd.
2293.30
20.00 (0.88%)
Max Healthcare Institute Ltd.
1012.45
2.85 (0.28%)
Mankind Pharma Ltd.
2381.10
8.40 (0.35%)
Lenskart Solutions Ltd.
494.10
-8.15 (1.62%)
Divi's Laboratories FAQs
The Buying Price of Divi's Laboratories share is 6638 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Divi's Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Divi's Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Divi's Laboratories shares is 68.76. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Divi's Laboratories shares is 10.53. Useful to assess the stock's value relative to its book value.
To assess Divi's Laboratories’s valuation compare Sector P/E, P/B which are 69.77 & 2.99 with sector averages, along with growth rates and financial metrics.
The Market Cap of Divi's Laboratories is 176218.04 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Divi's Laboratories share price is 7071.50 & 5636.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Divi's Laboratories belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
